AAAAAA

   
Results: 1-3 |
Results: 3
IN-VITRO ACTIVITY OF TROVAFLOXACIN AGAINST CLINICAL BACTERIAL ISOLATES FROM PATIENTS WITH CANCER
Authors: ROLSTON KVI HO DH LEBLANC B STREETER H DVORAK T
Citation: Kvi. Rolston et al., IN-VITRO ACTIVITY OF TROVAFLOXACIN AGAINST CLINICAL BACTERIAL ISOLATES FROM PATIENTS WITH CANCER, Journal of antimicrobial chemotherapy, 39, 1997, pp. 15-22
IN-VITRO ACTIVITY OF RAMOPLANIN (A NOVEL LIPOGLYCOPEPTIDE), VANCOMYCIN, AND TEICOPLANIN AGAINST GRAM-POSITIVE CLINICAL ISOLATES FROM CANCER-PATIENTS
Authors: ROLSTON KVI DHOLAKIA N HO DH LEBLANC B DVORAK T STREETER H
Citation: Kvi. Rolston et al., IN-VITRO ACTIVITY OF RAMOPLANIN (A NOVEL LIPOGLYCOPEPTIDE), VANCOMYCIN, AND TEICOPLANIN AGAINST GRAM-POSITIVE CLINICAL ISOLATES FROM CANCER-PATIENTS, Journal of antimicrobial chemotherapy, 38(2), 1996, pp. 265-269
IN-VITRO ACTIVITY OF FK-037, A NOVEL PARENTERAL CEPHALOSPORIN, AGAINST BACTERIAL ISOLATES FROM NEUTROPENIC CANCER-PATIENTS
Authors: DHOLAKIA N ROLSTON KVI HO DH LEBLANC B STREETER H DVORAK T BODEY GP
Citation: N. Dholakia et al., IN-VITRO ACTIVITY OF FK-037, A NOVEL PARENTERAL CEPHALOSPORIN, AGAINST BACTERIAL ISOLATES FROM NEUTROPENIC CANCER-PATIENTS, European journal of clinical microbiology & infectious diseases, 13(8), 1994, pp. 679-685
Risultati: 1-3 |